Organization, Description of Business, Basis of Presentation, Acquisitions and Recent Accounting Pronouncements - Pro Forma (Details) - Response Genetics, Inc. $ / shares in Units, $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2015
USD ($)
$ / shares
| |
| Pro Forma Financial Information | |
| Revenue | $ | $ 8,161 |
| Net loss | $ | $ (7,919) |
| Basic net loss per share (usd per share) | $ / shares | $ (0.75) |
| Dilutive net loss per share (usd per share) | $ / shares | $ (0.75) |
| X | ||||||||||
- Definition The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|